nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—Angioedema—Prednisolone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Regadenoson—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Regadenoson—Malaise—Prednisolone—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Regadenoson—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00414	0.00414	CcSEcCtD
Regadenoson—Syncope—Prednisolone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Regadenoson—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Regadenoson—Eye disorder—Betamethasone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Regadenoson—Asthma—Methotrexate—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Regadenoson—Angiopathy—Dexamethasone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Regadenoson—Angiopathy—Betamethasone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Regadenoson—Convulsion—Prednisolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Regadenoson—Hypertension—Prednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Regadenoson—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Regadenoson—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Regadenoson—Bradycardia—Prednisone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Regadenoson—Discomfort—Prednisolone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Regadenoson—Angioedema—Triamcinolone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Regadenoson—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Regadenoson—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Regadenoson—Erythema—Dexamethasone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Regadenoson—Erythema—Betamethasone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Regadenoson—Malaise—Triamcinolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Regadenoson—Malaise—Methylprednisolone—ankylosing spondylitis	0.00381	0.00381	CcSEcCtD
Regadenoson—Syncope—Triamcinolone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Regadenoson—Syncope—Methylprednisolone—ankylosing spondylitis	0.00378	0.00378	CcSEcCtD
Regadenoson—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Regadenoson—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Regadenoson—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Regadenoson—Shock—Prednisolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Regadenoson—Cough—Triamcinolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Regadenoson—Convulsion—Triamcinolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Regadenoson—Tachycardia—Prednisolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Regadenoson—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Regadenoson—Hypertension—Triamcinolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Regadenoson—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Regadenoson—Myalgia—Triamcinolone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Regadenoson—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Regadenoson—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Regadenoson—Eye disorder—Prednisone—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Regadenoson—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Regadenoson—Flushing—Prednisone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Regadenoson—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Regadenoson—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Regadenoson—Discomfort—Triamcinolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Regadenoson—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Regadenoson—Renal failure—Methotrexate—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Regadenoson—Angioedema—Dexamethasone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Regadenoson—Angioedema—Betamethasone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Regadenoson—Angiopathy—Prednisone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Regadenoson—Immune system disorder—Prednisone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Regadenoson—Malaise—Dexamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Regadenoson—Malaise—Betamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Regadenoson—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Regadenoson—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Regadenoson—Syncope—Dexamethasone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Regadenoson—Syncope—Betamethasone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Regadenoson—Shock—Triamcinolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Regadenoson—Insomnia—Prednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Regadenoson—Shock—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Regadenoson—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Regadenoson—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Regadenoson—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Regadenoson—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Regadenoson—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Regadenoson—Mental disorder—Prednisone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Regadenoson—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Regadenoson—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Regadenoson—Erythema—Prednisone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Regadenoson—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Regadenoson—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Regadenoson—Convulsion—Betamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Regadenoson—Convulsion—Dexamethasone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Regadenoson—Hypertension—Betamethasone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Regadenoson—Hypertension—Dexamethasone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Regadenoson—Myalgia—Dexamethasone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Regadenoson—Myalgia—Betamethasone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Regadenoson—Anxiety—Betamethasone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Regadenoson—Anxiety—Dexamethasone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Regadenoson—Discomfort—Betamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Regadenoson—Discomfort—Dexamethasone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Regadenoson—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Regadenoson—Pain—Prednisolone—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Regadenoson—Vision blurred—Prednisone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Regadenoson—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Regadenoson—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Regadenoson—Insomnia—Triamcinolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Regadenoson—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Regadenoson—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Regadenoson—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Regadenoson—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Regadenoson—Shock—Dexamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Regadenoson—Shock—Betamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Regadenoson—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Regadenoson—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Regadenoson—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Regadenoson—Tachycardia—Betamethasone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Regadenoson—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Regadenoson—Angioedema—Prednisone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Regadenoson—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Regadenoson—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Regadenoson—Malaise—Prednisone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Regadenoson—Eye disorder—Methotrexate—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Regadenoson—Syncope—Prednisone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Regadenoson—Tinnitus—Methotrexate—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Regadenoson—Urticaria—Prednisolone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Regadenoson—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Regadenoson—Pain—Triamcinolone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Regadenoson—Hypotension—Betamethasone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Regadenoson—Hypotension—Dexamethasone—ankylosing spondylitis	0.00293	0.00293	CcSEcCtD
Regadenoson—Angiopathy—Methotrexate—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Regadenoson—Immune system disorder—Methotrexate—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Regadenoson—Convulsion—Prednisone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Regadenoson—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Regadenoson—Hypertension—Prednisone—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Regadenoson—Arthralgia—Prednisone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Regadenoson—Myalgia—Prednisone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Regadenoson—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Regadenoson—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Regadenoson—Anxiety—Prednisone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Regadenoson—Insomnia—Betamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Regadenoson—Insomnia—Dexamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Regadenoson—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Regadenoson—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Regadenoson—Discomfort—Prednisone—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Regadenoson—Mental disorder—Methotrexate—ankylosing spondylitis	0.00281	0.00281	CcSEcCtD
Regadenoson—Erythema—Methotrexate—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Regadenoson—Urticaria—Triamcinolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Regadenoson—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Regadenoson—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Regadenoson—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Regadenoson—Shock—Prednisone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Regadenoson—Pain—Dexamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Regadenoson—Pain—Betamethasone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Regadenoson—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Regadenoson—Tachycardia—Prednisone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Regadenoson—Skin disorder—Prednisone—ankylosing spondylitis	0.00265	0.00265	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Regadenoson—Vision blurred—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Regadenoson—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Regadenoson—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Regadenoson—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Regadenoson—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Regadenoson—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Regadenoson—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Regadenoson—Malaise—Methotrexate—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Regadenoson—Urticaria—Dexamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Regadenoson—Urticaria—Betamethasone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Regadenoson—Dizziness—Prednisolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Regadenoson—Asthenia—Triamcinolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Regadenoson—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Regadenoson—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Regadenoson—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Regadenoson—Insomnia—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Regadenoson—Paraesthesia—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Regadenoson—Cough—Methotrexate—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Regadenoson—Convulsion—Methotrexate—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Regadenoson—Arthralgia—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Regadenoson—Chest pain—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Regadenoson—Myalgia—Methotrexate—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Regadenoson—Rash—Prednisolone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Regadenoson—Dermatitis—Prednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Regadenoson—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Regadenoson—Headache—Prednisolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Regadenoson—Discomfort—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Regadenoson—Dizziness—Triamcinolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Regadenoson—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Regadenoson—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Regadenoson—Asthenia—Betamethasone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Regadenoson—Asthenia—Dexamethasone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Regadenoson—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Regadenoson—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Regadenoson—Nausea—Prednisolone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Regadenoson—Skin disorder—Methotrexate—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Regadenoson—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Regadenoson—Vomiting—Triamcinolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Regadenoson—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Regadenoson—Rash—Triamcinolone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Regadenoson—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Regadenoson—Rash—Methylprednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Regadenoson—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Regadenoson—Urticaria—Prednisone—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Regadenoson—Headache—Triamcinolone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Regadenoson—Headache—Methylprednisolone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Regadenoson—Abdominal pain—Prednisone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Regadenoson—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Regadenoson—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00214	0.00214	CcSEcCtD
Regadenoson—Hypotension—Methotrexate—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Regadenoson—Dizziness—Betamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Regadenoson—Dizziness—Dexamethasone—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Regadenoson—Insomnia—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Regadenoson—Nausea—Triamcinolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Regadenoson—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Regadenoson—Nausea—Methylprednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Regadenoson—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Regadenoson—Somnolence—Methotrexate—ankylosing spondylitis	0.00203	0.00203	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Regadenoson—Vomiting—Betamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Regadenoson—Vomiting—Dexamethasone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Regadenoson—Rash—Dexamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Regadenoson—Rash—Betamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Regadenoson—Dermatitis—Betamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Regadenoson—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Regadenoson—Headache—Betamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Regadenoson—Headache—Dexamethasone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Regadenoson—Asthenia—Prednisone—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Regadenoson—Pain—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Regadenoson—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Regadenoson—Diarrhoea—Prednisone—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Regadenoson—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Regadenoson—Nausea—Betamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Regadenoson—Nausea—Dexamethasone—ankylosing spondylitis	0.00186	0.00186	CcSEcCtD
Regadenoson—Urticaria—Methotrexate—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Regadenoson—Dizziness—Prednisone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Regadenoson—Abdominal pain—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Regadenoson—Vomiting—Prednisone—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Regadenoson—Rash—Prednisone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Regadenoson—Dermatitis—Prednisone—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Regadenoson—Headache—Prednisone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Regadenoson—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Regadenoson—Asthenia—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Regadenoson—Nausea—Prednisone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Regadenoson—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Regadenoson—Dizziness—Methotrexate—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Regadenoson—Vomiting—Methotrexate—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Regadenoson—Rash—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Regadenoson—Dermatitis—Methotrexate—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Regadenoson—Headache—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Regadenoson—Nausea—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
